Annual report pursuant to Section 13 and 15(d)

Note 2 - Acquisitions (Tables)

v3.2.0.727
Note 2 - Acquisitions (Tables)
 12 Months Ended
Jun. 30, 2015
Notes Tables  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
 
 
Novus
 
 
Protein
-
Simple
 
 
CyVek
 
 
Bionostics
 
 
PrimeGene
 
                                         
Current assets
   $ 10,739     $ 19,660     $ 1,206     $ 9,605     $ 1,272  
Equipment
     1,266       1,983       971       2,180       546  
Other long-term assets
     40       554       19                  
Intangible Assets:
                                        
Developed technology
     5,010       39,200       20,200       14,400       2,200  
Trade name
     5,300       36,100       100       2,700       3,000  
Customer relationships
     14,400       101,600       600       41,000       9,100  
Non-compete agreements
     -       200       -        2,400        322  
Goodwill
     28,408       134,074       91,658       56,349       5.518  
Total assets acquired
     65,163       333,371       114,754       128,634       21,958  
                                         
Liabilities
     2,166       11,644       1,965       3,007       887  
Deferred income taxes, net
     2,875       21,674       (438 )     22,478       2,310  
Net assets
  $ 60,122     $ 300,053     $ 113,327     $ 103,149     $ 18,761  
Less fair-value of previous investment
     -       -       18,300       -       -  
Net assets acquired
     60,122       300,053       94,927       103,149       18,761  
                                         
Cash paid, net of cash acquired
   $ 60,122     $ 300,053     $ 59,927     $ 103,149     $ 6,031  
Contingent consideration payable
     -       -       35,000       -       12,730  
Net purchase price
   $ 60,122     $ 300,053     $ 94,927     $ 103,149     $ 18,761  
Condensed Income Statement [Table Text Block]
 
 
Novus
 
 
Protein
-
Simple
 
 
CyVek
 
                         
Net sales
   $ 21,092     $ 65,512     $ 735  
Net income (loss)
     (610
)
     (3,624
)
     (4,196
)
Amortization expense
     1,898       11,364       981  
Costs recognized on sale of acquired inventory
     1,946       1,444       64  
Business Acquisition, Pro Forma Information [Table Text Block]
 
 
For the Year Ended June, 30
 
 
 
2015
 
 
2014
 
                 
Net sales
   $ 457,270     $ 433,034  
Net income
     104,132       100,958